WAT Waters Corporation

Waters Corporation Presentation at the Goldman Sachs Healthcare CEOs Unscripted Conference to Be Audio Webcast Live

Waters Corporation (NYSE:WAT) Christopher J. O’Connell, Chief Executive Officer, will speak to the investment community at the Goldman Sachs Healthcare CEOs Unscripted: A View from the Top at the InterContinental Boston in Boston, MA on Thursday, January 5, 2017, at 1:45 PM Eastern Time.

Interested investors can access the live webcast of the presentation by logging on to Waters Corporation’s website, www.waters.com in the investor relations’ section and clicking on “Goldman Sachs Healthcare CEOs Unscripted Healthcare Conference.”

About Waters Corporation:

For over 5O years, Waters Corporation (NYSE:WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $2.0 billion in 2015, Waters is driving scientific discovery and operational excellence for customers worldwide.

EN
29/12/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Waters Corporation

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 21, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 18, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Waters Corporation: Key credit factors leading to Baa2 issuer rating

Our credit view of this issuer reflects its solid margins and cash generation, against its integration risks with BD Life Sciences combination.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 14, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Waters Corp: 1 director

A director at Waters Corp bought 1,000 shares at 306.340USD and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch